Xspray: Detailed data shows that HyNap-Dasa achieved formal BE
Research Note
2018-10-10
14:20
Xspray Pharma today reported detailed data from the previously reported bioequivalence (BE) study, showing that formal BE was achieved for HyNap-Dasa compared to Sprycel (dasatinib).
MS
Mathias Spinnars
Disclosures and disclaimers